NYSE: HNGE
Hinge Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for HNGE

Based on 12 analysts offering 12 month price targets for Hinge Health Inc

Min Forecast
$41.00-11.83%
Avg Forecast
$48.58+4.48%
Max Forecast
$60.00+29.03%

Should I buy or sell HNGE stock?

Based on 12 analysts offering ratings for Hinge Health Inc.

Strong Buy
Strong Buy
8 analysts 66.67%
Buy
4 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HNGE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HNGE as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HNGE stock forecasts and price targets.

HNGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-14
lockedlocked$00.00+00.00%2025-07-14
lockedlocked$00.00+00.00%2025-07-14Find Out Why
lockedlocked$00.00+00.00%2025-06-16
lockedlocked$00.00+00.00%2025-06-16
Raymond James
Bottom 10%
10
BuyInitiates Coverage On$45.00-3.23%2025-06-16
Piper Sandler
Bottom 13%
13
Strong BuyInitiates Coverage On$41.00-11.83%2025-06-16
Morgan Stanley
Top 26%
75
Strong BuyInitiates Coverage On$46.00-1.08%2025-06-16
Bank of America
Top 6%
95
Strong BuyInitiates Coverage On$42.00-9.68%2025-06-16
RBC Capital
Bottom 1%
1
BuyInitiates Coverage On$45.00-3.23%2025-06-16

1 of 2

Forecast return on equity

Is HNGE forecast to generate an efficient return?

Company
N/A
Industry
17.87%
Market
90.85%

Forecast return on assets

Is HNGE forecast to generate an efficient return on assets?

Company
N/A
Industry
13.83%

HNGE earnings per share forecast

What is HNGE's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$3.72
Avg 2 year Forecast
$0.01
Avg 3 year Forecast
$0.09

HNGE revenue forecast

What is HNGE's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$511.8M
Avg 2 year Forecast
$612.8M
Avg 3 year Forecast
$717.5M

HNGE vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
AMWL$8.04$8.13+1.06%Hold
CCLD$2.47$1.50-39.27%Hold
BFRG$1.50N/AN/A
BTSG$20.10$27.33+35.99%Strong Buy
ACON$7.41N/AN/A

Hinge Health Stock Forecast FAQ

Is Hinge Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: HNGE) stock is to Strong Buy HNGE stock.

Out of 12 analysts, 8 (66.67%) are recommending HNGE as a Strong Buy, 4 (33.33%) are recommending HNGE as a Buy, 0 (0%) are recommending HNGE as a Hold, 0 (0%) are recommending HNGE as a Sell, and 0 (0%) are recommending HNGE as a Strong Sell.

If you're new to stock investing, here's how to buy Hinge Health stock.

What is HNGE's earnings growth forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 17.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.89%.

Hinge Health's earnings in 2025 is N/A.On average, 5 Wall Street analysts forecast HNGE's earnings for 2025 to be -$290,340,800, with the lowest HNGE earnings forecast at -$520,304,442, and the highest HNGE earnings forecast at $42,903,665. On average, 5 Wall Street analysts forecast HNGE's earnings for 2026 to be $936,080, with the lowest HNGE earnings forecast at -$46,803,998, and the highest HNGE earnings forecast at $57,724,931.

In 2027, HNGE is forecast to generate $7,278,022 in earnings, with the lowest earnings forecast at -$43,683,731 and the highest earnings forecast at $83,467,129.

What is HNGE's revenue growth forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.67%.

Hinge Health's revenue in 2025 is N/A.On average, 7 Wall Street analysts forecast HNGE's revenue for 2025 to be $39,924,434,177, with the lowest HNGE revenue forecast at $39,541,577,475, and the highest HNGE revenue forecast at $40,922,295,410. On average, 7 Wall Street analysts forecast HNGE's revenue for 2026 to be $47,802,483,086, with the lowest HNGE revenue forecast at $46,999,014,458, and the highest HNGE revenue forecast at $49,144,197,690.

In 2027, HNGE is forecast to generate $55,968,922,629 in revenue, with the lowest revenue forecast at $55,224,037,004 and the highest revenue forecast at $57,771,734,618.

What is HNGE's forecast return on assets (ROA) for 2025-2028?

(NYSE: HNGE) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 13.83%.

What is HNGE's Price Target?

According to 12 Wall Street analysts that have issued a 1 year HNGE price target, the average HNGE price target is $48.58, with the highest HNGE stock price forecast at $60.00 and the lowest HNGE stock price forecast at $41.00.

On average, Wall Street analysts predict that Hinge Health's share price could reach $48.58 by Jul 14, 2026. The average Hinge Health stock price prediction forecasts a potential upside of 4.48% from the current HNGE share price of $46.50.

What is HNGE's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that HNGE's EPS will be -$3.72 for 2025, with the lowest EPS forecast at -$6.67, and the highest EPS forecast at $0.55. On average, analysts forecast that HNGE's EPS will be $0.01 for 2026, with the lowest EPS forecast at -$0.60, and the highest EPS forecast at $0.74. In 2027, HNGE's EPS is forecast to hit $0.09 (min: -$0.56, max: $1.07).

What is HNGE's forecast return on equity (ROE) for 2025-2028?

(NYSE: HNGE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.